Effects of intratracheal tumor necrosis factor-alpha plasmid vector on lipopolysaccharide lethality and lung injury in mice.
Effects of intratracheal tumor necrosis factor-alpha plasmid vector on lipopolysaccharide lethality and lung injury in mice.
复制标题
气管内肿瘤坏死因子-α质粒载体对小鼠脂多糖致死率和肺损伤的影响。
DOI:
10.1080/01902140490517791
复制
发表时间:
2004
影响因子:
1.7
通讯作者:
Jackson,RobertM
中科院分区:
文献类型:
--
作者:
Wright,MarcienneM;Powell,CharlesS;Jackson,RobertM
Bacterial lipopolysaccharide (LPS) causes acute lung injury (ALI) and contributes to inflammation in the acute respiratory distress syndrome (ARDS) and sepsis, making mechanisms of resistance to LPS critically important in clinical settings. The authors postulated that intratracheal administration of a plasmid (pcDNA3.0-rTNFα) encoding rat tumor necrosis factor-alpha (TNF-α) would increase resistance of mice to LPS-induced ALI or mortality. They investigated the time course and dose-response for development of LPS-induced ALI in C57/BL6 mice and sought possible protective effects of 100 µg pcDNA3.0-rTNFα intratracheally 1, 2, or 3 weeks before LPS challenge. Lung myeloperoxidase (MPO) activity and alveolar lavage fluid (BALF) cell counts increased significantly 48 hours after intraperitoneal (IP) LPS challenges. After pcDNA3.0-rTNFα pretreatment, mice challenged with LPS had lower lung/body weight ratios than mice treated with pcDNA3.0; however, other indices of lung injury did not differ. Survival of mice challenged with lethal IP LPS 2 weeks after intratracheal pcDNA3.0-rTNFα vector improved significantly, compared to mice pretreated with the control vector, pcDNA3.0. However, pcDNA3.0-pretreated mice tolerated LPS challenge less well than saline-pretreated controls. LPS causes neutrophilic lung injury and mortality, but pcDNA3.0-TNFα does not prevent ALI due to LPS. Intratracheal pcDNA3.0-rTNFα pretreatment significantly improves survival of mice after LPS challenge, compared to those pretreated with pcDNA3.0.